Literature DB >> 29636972

Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Brett Wanamaker1, Thomas Cascino1, Vallerie McLaughlin1, Hakan Oral1, Rakesh Latchamsetty1, Konstantinos C Siontis1.   

Abstract

Atrial arrhythmias, including atrial fibrillation and atrial flutter, are common in patients with pulmonary hypertension and are closely associated with clinical decompensation and poor clinical outcomes. The mechanisms of arrhythmogenesis and subsequent clinical decompensation are reviewed. Practical implications and current evidence for the management of atrial arrhythmias in patients with pulmonary hypertension are summarised.

Entities:  

Keywords:  Atrial arrhythmia; antiarrhythmia drug treatment; anticoagulation; cather ablation; prognosis; pulmonary hypertension

Year:  2018        PMID： 29636972      PMCID： PMC5889803          DOI： 10.15420/aer.2018.3.2

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  56 in total

1.  One Year Incidence of Atrial Septal Defect after PV Isolation: A Comparison Between Conventional Radiofrequency and Cryoballoon Ablation.

Authors:  Giacomo Mugnai; Juan Sieira; Giuseppe Ciconte; Marta Soriano Hervas; Ghazala Irfan; Yukio Saitoh; Burak Hünük; Erwin Ströker; Vedran Velagic; Kristel Wauters; Claudio Tondo; Giulio Molon; Carlo De Asmundis; Pedro Brugada; Gian-Battista Chierchia
Journal:  Pacing Clin Electrophysiol       Date:  2015-06-12       Impact factor: 1.976

Review 2.  Atrial fibrillation pathophysiology and prognosis: insights from cardiovascular imaging.

Authors:  Konstantinos C Siontis; Jeffrey B Geske; Bernard J Gersh
Journal:  Circ Cardiovasc Imaging       Date:  2015-06       Impact factor: 7.792

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

5.  Electrical remodelling of the left and right atria due to rheumatic mitral stenosis.

Authors:  Bobby John; Martin K Stiles; Pawel Kuklik; Sunil T Chandy; Glenn D Young; Lorraine Mackenzie; Lukasz Szumowski; George Joseph; Jacob Jose; Stephen G Worthley; Jonathan M Kalman; Prashanthan Sanders
Journal:  Eur Heart J       Date:  2008-07-10       Impact factor: 29.983

6.  Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension.

Authors:  Dirk Bandorski; Harilaos Bogossian; Anja Ecke; Christoph Wiedenroth; Ekkehard Gruenig; Nicola Benjamin; Matthias Arlt; Werner Seeger; Eckhard Mayer; Ardeschir Ghofrani; Reinhard Hoeltgen; Henning Gall
Journal:  Cardiol J       Date:  2016-07-01       Impact factor: 2.737

7.  The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension.

Authors:  Katarzyna Małaczyńska-Rajpold; Anna Komosa; Krzysztof Błaszyk; Aleksander Araszkiewicz; Magdalena Janus; Anna Olasińska-Wiśniewska; Stanisław Jankiewicz; Maciej Mączyński; Tatiana Mularek-Kubzdela
Journal:  Heart Lung Circ       Date:  2015-11-02       Impact factor: 2.975

8.  Supraventricular Arrhythmias in Patients With Pulmonary Arterial Hypertension.

Authors:  Margherita Cannillo; Walter Grosso Marra; Sebastiano Gili; Fabrizio D'Ascenzo; Mara Morello; Lorena Mercante; Elisa Mistretta; Davide Salera; Domenica Zema; Arianna Bissolino; Enrico Fusaro; Sebastiano Marra; Daniela Libertucci; Fiorenzo Gaita
Journal:  Am J Cardiol       Date:  2015-10-09       Impact factor: 2.778

Review 9.  Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

Authors:  Rakesh Gopinathannair; Susan P Etheridge; Francis E Marchlinski; Francis G Spinale; Dhanunjaya Lakkireddy; Brian Olshansky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

10.  Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load.

Authors:  Thomas S Metkus; Christopher J Mullin; E Wilson Grandin; J Eduardo Rame; Emmanouil Tampakakis; Steven Hsu; Todd M Kolb; Rachel Damico; Paul M Hassoun; David A Kass; Stephen C Mathai; Ryan J Tedford
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240
View more
  15 in total

Review 1.  Management of arrhythmias in pulmonary hypertension.

Authors:  S Ashwin Reddy; Sarah L Nethercott; Bharat V Khialani; Andrew A Grace; Claire A Martin
Journal:  J Interv Card Electrophysiol       Date:  2021-04-05       Impact factor: 1.900

Review 2.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

3.  While your PAH patients skip by, don't forget to check their rhythm ….

Authors:  Ryan Davey
Journal:  Pulm Circ       Date:  2018 Apr-Jun       Impact factor: 3.017

4.  Management of pulmonary arterial hypertension in patients aged over 65 years.

Authors:  Olivier Sitbon; Luke Howard
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

Review 5.  COVID-19 and arrhythmia: An overview.

Authors:  Joseph A Varney; Vinh S Dong; Tiffany Tsao; Mariam S Sabir; Amanda T Rivera; Suhaib Ghula; Kevin Emmanuel Moriles; Mohana Laasya Cherukuri; Rahim Fazal; Chelsea B Azevedo; Rana Mk Mohamed; Garrett R Jackson; Shannon E Fleming; Diana E Rochez; Kirellos S Abbas; Jaffer H Shah; Le Huu Nhat Minh; Faizel Osman; Samir M Rafla; Nguyen Tien Huy
Journal:  J Cardiol       Date:  2021-12-01       Impact factor: 3.159

6.  Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis.

Authors:  Lukasz Szarpak; Krzysztof J Filipiak; Aleksandra Skwarek; Michal Pruc; Mansur Rahnama; Andrea Denegri; Marta Jachowicz; Malgorzata Dawidowska; Aleksandra Gasecka; Milosz J Jaguszewski; Lukasz Iskrzycki; Zubaid Rafique
Journal:  Cardiol J       Date:  2021-12-13       Impact factor: 2.737

7.  The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.

Authors:  Roddy Hiram; Feng Xiong; Patrice Naud; Jiening Xiao; Martin Sirois; Jean-François Tanguay; Jean-Claude Tardif; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 8.  The Role of Hydrogen Sulfide in Respiratory Diseases.

Authors:  Saadullah Khattak; Qian-Qian Zhang; Muhammad Sarfraz; Pir Muhammad; Ebenezeri Erasto Ngowi; Nazeer Hussain Khan; Saqib Rauf; Yi-Zhen Wang; Hui-Wen Qi; Di Wang; Attia Afzal; Xin-Ying Ji; Dong-Dong Wu
Journal:  Biomolecules       Date:  2021-05-01

9.  Anticoagulation in pulmonary arterial hypertension: a decision analysis.

Authors:  Arun Jose; Mark H Eckman; Jean M Elwing
Journal:  Pulm Circ       Date:  2019-12-23       Impact factor: 3.017

10.  Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients With Pulmonary Hypertension: Feasibility and Long-Term Outcome.

Authors:  Bin Zhou; Yong-Jian Zhu; Zheng-Qin Zhai; Si-Xian Weng; Ya-Zhe Ma; Feng-Yuan Yu; Ying-Jie Qi; Yi-Zhou Jiang; Xin Gao; Xi-Qi Xu; Xin Jiang; Zhi-Cheng Jing; Min Tang
Journal:  Front Physiol       Date:  2021-06-18       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.